Suppr超能文献

微视野检查作为一种诊断工具,用于检测多发性硬化症中的早期、亚临床视网膜损伤和视力障碍。

Microperimetry as a diagnostic tool for the detection of early, subclinical retinal damage and visual impairment in multiple sclerosis.

机构信息

Vision Research Center, Department of Ophthalmology, School of Medicine, University of Missouri - Kansas City, 2411 Holmes St, Kansas City, MO, 64108, USA.

Harry S Truman Memorial Veterans' Hospital, Department of Surgery (Ophthalmology section), 800 Hospital Drive, Columbia, MO, 65201, USA.

出版信息

BMC Ophthalmol. 2020 Sep 11;20(1):367. doi: 10.1186/s12886-020-01620-9.

Abstract

BACKGROUND

A majority of multiple sclerosis patients experience visual impairment, often as the initial presenting symptom of the disease. While structural changes in the retinal nerve fiber layer and optic nerve have demonstrated correlations with brain atrophy in multiple sclerosis using magnetic resonance imaging, a non-invasive, cost-effective, and clinically efficacious modality to identify early damage and facilitate prompt therapeutic intervention to slow the progression of multiple sclerosis and its ocular manifestations, is still urgently needed. In this study, we sought to determine the role of macular sensitivity measured by microperimetry in the detection of subclinical multiple sclerosis-related retinal damage and visual dysfunction.

METHODS

This cross-sectional observational case-control study involved population-based samples of multiple sclerosis patients and age-, race-, and gender-matched healthy control subjects. Among the key criteria for the multiple sclerosis patients were diagnosis by the McDonald criteria, visual acuity greater than 20/25, and no history of optic neuritis. Macular sensitivity and average macular thickness were measured in all subjects using microperimetry and spectral-domain optical coherence tomography, respectively. Pearson correlation coefficients were measured using bivariate correlations. Sample means, mean differences, and 95% confidence intervals were calculated using independent sample t-tests.

RESULTS

Twenty-eight eyes from 14 MS patients and 18 eyes from 9 control subjects were included. Mean macular sensitivity of control subjects and multiple sclerosis patients in decibels was 18.2 ± 0.4 and 16.5 ± 0.4, respectively, corresponding to a mean difference of 1.7 (95% CI, 1.1-2.4; P < 0.001). Macular sensitivity was positively correlated with macular thickness in multiple sclerosis patients (r = 0.49, P = 0.01) but not control subjects (r = 0.15, P = 0.55).

CONCLUSIONS

Macular sensitivity as measured by microperimetry was decreased in multiple sclerosis patients with normal visual acuity and no history of optic neuritis. Furthermore, macular sensitivity demonstrated a positive correlation with macular thickness as measured by optical coherence tomography. As such, microperimetry may represent a non-invasive and efficient method to identify signs of subclinical visual dysfunction that correspond with early macular architectural changes characteristic of multiple sclerosis.

摘要

背景

大多数多发性硬化症患者都有视力障碍,通常是这种疾病的首发症状。虽然使用磁共振成像已经证明视网膜神经纤维层和视神经的结构变化与多发性硬化症的脑萎缩有关,但仍迫切需要一种非侵入性、具有成本效益且临床有效的方法来识别早期损伤,并促进及时的治疗干预,以减缓多发性硬化症及其眼部表现的进展。在这项研究中,我们试图确定微视野计测量的黄斑敏感性在检测亚临床多发性硬化相关视网膜损伤和视觉功能障碍中的作用。

方法

本研究为基于人群的多发性硬化症患者和年龄、种族和性别匹配的健康对照组的病例对照研究。多发性硬化症患者的关键标准包括 McDonald 标准诊断、视力大于 20/25 和没有视神经炎病史。使用微视野计和光谱域光学相干断层扫描分别测量所有受试者的黄斑敏感性和平均黄斑厚度。使用双变量相关性测量 Pearson 相关系数。使用独立样本 t 检验计算样本均值、均值差异和 95%置信区间。

结果

纳入了 14 例多发性硬化症患者的 28 只眼和 9 例对照组的 18 只眼。对照组和多发性硬化症患者的平均黄斑敏感性以分贝为单位,分别为 18.2±0.4 和 16.5±0.4,平均差异为 1.7(95%置信区间,1.1-2.4;P<0.001)。多发性硬化症患者的黄斑敏感性与黄斑厚度呈正相关(r=0.49,P=0.01),但在对照组中无相关性(r=0.15,P=0.55)。

结论

视力正常且无视神经炎病史的多发性硬化症患者的微视野计测量的黄斑敏感性降低。此外,黄斑敏感性与光学相干断层扫描测量的黄斑厚度呈正相关。因此,微视野计可能是一种非侵入性和有效的方法,可以识别与多发性硬化症特征性的早期黄斑结构变化相对应的亚临床视觉功能障碍迹象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b4b/7488495/f2f0b708a88a/12886_2020_1620_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验